STRUCTURE-ACTIVITY ANALYSIS OF SYNTHETIC ALPHA-THROMBIN-RECEPTOR-ACTIVATING PEPTIDES

被引:23
|
作者
VANOBBERGHENSCHILLING, E [1 ]
RASMUSSEN, UB [1 ]
VOURETCRAVIARI, V [1 ]
LENTES, KU [1 ]
PAVIRANI, A [1 ]
POUYSSEGUR, J [1 ]
机构
[1] TRANSGENE SA,F-67082 STRASBOURG,FRANCE
关键词
D O I
10.1042/bj2920667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Thrombin stimulates G-protein-coupled effectors leading to secretion and aggregation in human platelets, and to a mitogenic response in CCL39 hamster fibroblasts. Alpha-Thrombin receptors can be activated by synthetic peptides corresponding to the receptor sequence starting with serine-42, at the proposed cleavage site. We have previously determined that the agonist domain of receptor-activating peptides resides within the five N-terminal residues [Vouret-Craviari, Van Obberghen-Schilling, Rasmussen, Pavirani, Lecocq and Pouyssegur (1992) Mol. Biol. Cell. 3, 95-102], although the 7-residue peptide (SFFLRNP) corresponding to the hamster alpha-thrombin receptor was 10 times more potent than the 5-residue peptide for activation of human platelets. In the present study we have analysed the role of individual amino acids in receptor activation by using a series of modified hexa- or hepta-peptides derived from the human alpha-thrombin-receptor sequence. Cellular events examined here include phospholipase C activation, adenylyl cyclase inhibition and DNA synthesis stimulation in non-transformed CCL39 fibroblasts and a tumorigenic variant of that line (A71 cells). Modification of the peptide sequence had similar functional consequence for each of the assays described, indicating that either a unique receptor or pharmacologically indistinguishable receptor subtypes activate distinct G-protein signalling pathways. Furthermore, we found that: (1) the N-terminal serine can be replaced by small or intermediately sized amino acids (+/- hydroxyl groups) without loss of activity. However, its replacement by an aromatic side-chain or omission of the N-terminal amino group severely reduces activity. (2) An aromatic side-chain on the penultimate N-terminal residue appears to play a critical role since phenylalanine in this position can be substituted by tyrosine without complete loss of activity whereas an alanine in its place is not tolerated. (3) Deletion of the first, second or third N-terminal residue leads to a loss of activity, suggesting that a defined spacing of more than one structural component may be important for ligand-receptor interaction. Finally, we did not observe an antagonistic effect of the inactive peptides on phospholipase C activation or DNA synthesis induced by alpha-thrombin (1 nM) or SFLLRNP (3 muM).
引用
收藏
页码:667 / 671
页数:5
相关论文
共 50 条
  • [41] The structure-activity relationship of marine peptides: a review
    Ashaolu, Tolulope Joshua
    Pham, Bang Phuong
    Molnar, Zoltan
    Varga, Laszlo
    Greff, Babett
    INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2024, 59 (07): : 4437 - 4445
  • [42] STRUCTURE-ACTIVITY STUDIES ON SYNTHETIC ANALOGS TO VASOACTIVE PEPTIDES DERIVED FROM HUMAN-FIBRINOGEN
    BELEW, M
    GERDIN, B
    LARSSON, LE
    LINDEBERG, G
    RAGNARSSON, U
    SALDEEN, T
    WALLIN, R
    BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 632 (01) : 87 - 94
  • [43] STRUCTURE-ACTIVITY STUDIES ON SYNTHETIC PEPTIDES INHIBITING HERPES-SIMPLEX VIRUS RIBONUCLEOTIDE REDUCTASE
    GAUDREAU, P
    MICHAUD, J
    COHEN, EA
    LANGELIER, Y
    BRAZEAU, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (26) : 12413 - 12416
  • [44] Structure-activity studies of B-1 receptor-related peptides - Antagonists
    Gobeil, F
    Neugebauer, W
    Filteau, C
    Jukic, D
    Allogho, SN
    Pheng, LH
    NguyenLe, XK
    Blouin, D
    Regoli, D
    HYPERTENSION, 1996, 28 (05) : 833 - 839
  • [45] STRUCTURE-ACTIVITY STUDIES OF BRADYKININ AND RELATED PEPTIDES - B2-RECEPTOR ANTAGONISTS
    RHALEB, NE
    TELEMAQUE, S
    ROUISSI, N
    DION, S
    JUKIC, D
    DRAPEAU, G
    REGOLI, D
    HYPERTENSION, 1991, 17 (01) : 107 - 115
  • [46] Structure-based design, Fourrier transformed infrared and Raman studies and structure-activity relationships of synthetic peptides with trans/cis-cinnamic and dihydrocinnamic acids as inhibitors for thrombin
    Clement, CC
    Matthaeus, C
    Manfred, P
    FASEB JOURNAL, 2006, 20 (05): : A898 - A898
  • [47] Structure-activity analysis of ginkgolide binding in the glycine receptor pore
    Heads, Judith A.
    Hawthorne, Rebecca L.
    Lynagh, Timothy
    Lynch, Joseph W.
    JOURNAL OF NEUROCHEMISTRY, 2008, 105 (04) : 1418 - 1427
  • [48] ACTIONS OF THROMBIN AND THROMBIN RECEPTOR PEPTIDE ANALOGS IN GASTRIC AND AORTIC SMOOTH-MUSCLE - DEVELOPMENT OF BIOASSAYS FOR STRUCTURE-ACTIVITY STUDIES
    YANG, SG
    LANIYONU, A
    SAIFEDDINE, M
    MOORE, GJ
    HOLLENBERG, MD
    LIFE SCIENCES, 1992, 51 (17) : 1325 - 1332
  • [49] Tenofovir: Structure-Activity Relationship and Synthetic Methods
    Leite, Debora I.
    Faria, Jessica V.
    de Azevedo, Liviane D.
    Figueiredo, Yasmin V.
    Martins, Wagner Alexandre
    Bianco, Maria da Conceicao A. D.
    Bernardino, Alice Maria R.
    Bastos, Monica M.
    Boechat, Nubia
    REVISTA VIRTUAL DE QUIMICA, 2015, 7 (06) : 2347 - 2376
  • [50] Structure-activity relationships of synthetic cardiac glycosides
    Takechi, M
    Uno, C
    Tanaka, Y
    PHYTOCHEMISTRY, 1996, 41 (01) : 125 - 127